Market Research Logo

Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015

Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Cardiac Markers Tests - Medical Devices Pipeline Assessment, 2015 provides an overview of Cardiac Markers Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Markers Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch dat.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Markers Tests Overview
3 Products under Development
3.1 Cardiac Markers Tests - Pipeline Products by Stage of Development
3.2 Cardiac Markers Tests - Pipeline Products by Segment
3.3 Cardiac Markers Tests - Pipeline Products by Territory
3.4 Cardiac Markers Tests - Pipeline Products by Regulatory Path
3.5 Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
3.6 Cardiac Markers Tests - Ongoing Clinical Trials
4 Cardiac Markers Tests - Pipeline Products under Development by Companies
4.1 Cardiac Markers Tests Companies - Pipeline Products by Stage of Development
4.2 Cardiac Markers Tests - Pipeline Products by Stage of Development
5 Cardiac Markers Tests Companies and Product Overview
5.1 3PrimeDx, Inc. Company Overview
5.2 Abbott Diagnostics Company Overview
5.3 ACS Biomarker Company Overview
5.4 Adaltis S.r.l. Company Overview
5.5 AgPlus Diagnostics LTD Company Overview
5.6 Alere Inc. Company Overview
5.7 Alfa Scientific Designs, Inc. Company Overview
5.8 Alfa Wassermann Diagnostic Technologies, LLC Company Overview
5.9 Alfa Wassermann, Inc. Company Overview
5.10 Amdix B.V. Company Overview
5.11 Analyticon Biotechnologies AG Company Overview
5.12 Applied Proteomics, Inc. Company Overview
5.13 Arrayit Diagnostics, Inc. Company Overview
5.14 Astute Medical, Inc. Company Overview
5.15 Aterovax SA Company Overview
5.16 Axela Inc. Company Overview
5.17 AXO Science S.A.S. Company Overview
5.18 Beckman Coulter, Inc. Company Overview
5.19 BG Medicine, Inc. Company Overview
5.20 Biocartis SA Company Overview
5.21 Biomarker Design Forschungs GmbH Company Overview
5.22 bioMerieux S.A. Company Overview
5.23 BiOracle Limited Company Overview
5.24 Bio-Rad Laboratories, Inc. Company Overview
5.25 Biouniversa s.r.l. Company Overview
5.26 CardioGenics Inc. Company Overview
5.27 Cavadis B.V. Company Overview
5.28 Cellgenex Diagnostics Company Overview
5.29 Centice Corporation Company Overview
5.30 Children's Hospital Boston Company Overview
5.31 China Medical Technologies, Inc. Company Overview
5.32 China Sky One Medical, Inc. Company Overview
5.33 Cleveland HeartLab, Inc. Company Overview
5.34 Co-Diagnostics HBDC, Inc. Company Overview
5.35 CompanDX Ltd. Company Overview
5.36 Corgenix Medical Corporation Company Overview
5.37 Corgenix, Inc. Company Overview
5.38 Coris BioConcept Company Overview
5.39 Courtagen Life Sciences, Inc. Company Overview
5.40 CPD, LLC Company Overview
5.41 Critical Diagnostics Company Overview
5.42 DestiNA Genomics Ltd Company Overview
5.43 diaDexus, Inc. (Inactive) Company Overview
5.44 Diagnoptics Technologies B.V. Company Overview
5.45 DiaPat GmbH Company Overview
5.46 ELITech Group Company Overview
5.47 EnCare Biotech B.V. Company Overview
5.48 Firalis SAS Company Overview
5.49 Fundacio Clinic per a la Recerca Biomedica Company Overview
5.50 Gamma Therapeutics, Inc. Company Overview
5.51 GeneNews Limited Company Overview
5.52 Genesis Detection Systems, Inc. Company Overview
5.53 Global Genomics Group, LLC Company Overview
5.54 Grifols, S.A. Company Overview
5.55 Hannover Medical School Company Overview
5.56 Hospices Civils de Lyon Company Overview
5.57 IMMUNARRAY LTD. Company Overview
5.58 Immunodiagnostic Systems Holdings plc Company Overview
5.59 Infigo Diagnostics Ltd Company Overview
5.60 infYnity biomarkers S.A.S. Company Overview
5.61 Insilicos LLC Company Overview
5.62 Institut National de la Sante et de la Recherche Medicale Company Overview
5.63 iXensor Co. Ltd. Company Overview
5.64 Kamiya Biomedical Company Company Overview
5.65 KineMed, Inc. Company Overview
5.66 King's College London Company Overview
5.67 LipoScience, Inc. Company Overview
5.68 Marshall University Company Overview
5.69 Mayo Clinic. Company Overview
5.70 Medical University of South Carolina Company Overview
5.71 Mediomics, LLC Company Overview
5.72 MedMira Inc. Company Overview
5.73 MetaboGen AB Company Overview
5.74 Metanomics Health GmbH Company Overview
5.75 Mindray Medical International Limited Company Overview
5.76 MMBiosensing, LLC Company Overview
5.77 Nanosphere, Inc. Company Overview
5.78 NorthShore University Health System Company Overview
5.79 Nuclea Biotechnologies Inc. Company Overview
5.80 One Drop Diagnostics Company Overview
5.81 Oran Diagnostics, LLC Company Overview
5.82 Oregon Health & Science University Company Overview
5.83 Ortho-Clinical Diagnostics Inc. Company Overview
5.84 Pacific Nanoscience, Inc. Company Overview
5.85 Parque Científico de Madrid Company Overview
5.86 Prevencio, LLC Company Overview
5.87 Prognosys LLC Company Overview
5.88 Pronota NV Company Overview
5.89 Proof Centre of Excellence Company Overview
5.90 Proplex Technologies, Llc Company Overview
5.91 Proteome Sciences Plc Company Overview
5.92 QLIDA Diagnostics Company Overview
5.93 Quest Diagnostics Incorporated Company Overview
5.94 Radiometer Medical ApS Company Overview
5.95 Randox Laboratories Limited Company Overview
5.96 Rheonix, Inc. Company Overview
5.97 Rice University Company Overview
5.98 RMIT University Company Overview
5.99 Rna Diagnostics Inc. Company Overview
5.100 Roche Diagnostics International Ltd. Company Overview
5.101 ROS Technologies, Inc Company Overview
5.102 Rosetta Genomics, Ltd. Company Overview
5.103 SATT South East Company Overview
5.104 Siemens Healthcare Diagnostics Inc. Company Overview
5.105 Singulex, Inc. Company Overview
5.106 Skyline Diagnostics BV Company Overview
5.107 SomaLogic, Inc. Company Overview
5.108 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.109 Tcoag Us Inc Company Overview
5.110 Tethys Bioscience, Inc. Company Overview
5.111 The Johns Hopkins University Company Overview
5.112 The Pennsylvania State University Company Overview
5.113 The University of Adelaide Company Overview
5.114 The University of Tokyo Company Overview
5.115 Thermo Fisher Scientific Inc. Company Overview
5.116 ThreeFold Sensors (Inactive) Company Overview
5.117 TissueNetix, Inc. Company Overview
5.118 Toshiba Medical Systems Corporation Company Overview
5.119 Tosoh Bioscience, Inc. Company Overview
5.120 True Diagnostics, Inc. Company Overview
5.121 Universite de Montreal Company Overview
5.122 University College Dublin Company Overview
5.123 University of California, San Diego Company Overview
5.124 University of California, San Francisco Company Overview
5.125 University of Colorado Company Overview
5.126 University of Illinois Company Overview
5.127 University of Nebraska Company Overview
5.128 University of Oslo Company Overview
5.129 University of Otago Company Overview
5.130 University of Texas Medical Branch at Galveston Company Overview
5.131 Vaiomer, SAS Company Overview
5.132 Vanderbilt University Company Overview
5.133 VEGA Ltd Company Overview
5.134 Vermillion, Inc. Company Overview
5.135 Vital Diagnostics, Inc. Company Overview
5.136 Warnex Inc. (Inactive) Company Overview
5.137 Washington University School of Medicine Company Overview
6 Cardiac Markers Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Cardiac Markers Tests - Pipeline Products by Stage of Development
Table 2: Cardiac Markers Tests - Pipeline Products by Segment
Table 3: Cardiac Markers Tests - Pipeline Products by Territory
Table 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path
Table 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Markers Tests - Ongoing Clinical Trials
Table 7: Cardiac Markers Tests Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Markers Tests - Pipeline Products by Stage of Development
Table 9: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PulsePredic Test - Product Status
Table 11: PulsePredic Test - Product Description
Table 12: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status
Table 14: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description
Table 15: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Status
Table 16: ARCHITECT c16000 System - High Sensitive Troponin - I Assay - Product Description
Table 17: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Status
Table 18: ARCHITECT c4000 Integrated System - Galectin-3 Assay - Product Description
Table 19: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
Table 20: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
Table 21: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status
Table 22: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description
Table 23: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
Table 24: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
Table 25: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Status
Table 26: ARCHITECT ci16200 Integrated System - High Sensitive Troponin-I Assay - Product Description
Table 27: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status
Table 28: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description
Table 29: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Status
Table 30: ARCHITECT ci4100 Integrated System - High Sensitive Troponin-I Assay - Product Description
Table 31: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status
Table 32: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description
Table 33: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Status
Table 34: ARCHITECT ci8200 Integrated System - High Sensitive Troponin-I Assay - Product Description
Table 35: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Status
Table 36: ARCHITECT ci8200 Integrated System - NT Pro BNP Assay - Product Description
Table 37: ARCHITECT i1000SR - NT Pro BNP Assay - Product Status
Table 38: ARCHITECT i1000SR - NT Pro BNP Assay - Product Description
Table 39: ARCHITECT i2000SR - NT Pro BNP Assay - Product Status
Table 40: ARCHITECT i2000SR - NT Pro BNP Assay - Product Description
Table 41: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Status
Table 42: ARCHITECT i4000SR Integrated System - High Sensitive Troponin-I Assay - Product Description
Table 43: ACS Biomarker Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Multi-marker Heart Failure Assay - Product Status
Table 45: Multi-marker Heart Failure Assay - Product Description
Table 46: Adaltis S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 47: CLIAgen Cardiac Marker Assay - Product Status
Table 48: CLIAgen Cardiac Marker Assay - Product Description
Table 49: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 50: AgPlus Diagnostic System - Troponin I Assay - Product Status
Table 51: AgPlus Diagnostic System - Troponin I Assay - Product Description
Table 52: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Afinion hsCRP Assay - Product Status
Table 54: Afinion hsCRP Assay - Product Description
Table 55: Galectin-3 Test - Triage Meter Pro - Product Status
Table 56: Galectin-3 Test - Triage Meter Pro - Product Description
Table 57: Alfa Scientific Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Status
Table 59: Instant-View Cardiac 3-in-1 Whole Blood/Serum Test - Product Description
Table 60: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 61: ACE Axcel System - Apo A1 Assay - Product Status
Table 62: ACE Axcel System - Apo A1 Assay - Product Description
Table 63: ACE Axcel System - Apo B Assay - Product Status
Table 64: ACE Axcel System - Apo B Assay - Product Description
Table 65: ACE Axcel System - HsCRP Assay - Product Status
Table 66: ACE Axcel System - HsCRP Assay - Product Description
Table 67: Alfa Wassermann, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 68: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status
Table 69: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description
Table 70: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status
Table 71: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description
Table 72: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Chitotriosidase Biomarker - Atherosclerosis - Product Status
Table 74: Chitotriosidase Biomarker - Atherosclerosis - Product Description
Table 75: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Turbitex APO A1 - Product Status
Table 77: Turbitex APO A1 - Product Description
Table 78: Turbitex APO B - Product Status
Table 79: Turbitex APO B - Product Description
Table 80: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: API Diagnostic Test - Cardiovascular Disease - Product Status
Table 82: API Diagnostic Test - Cardiovascular Disease - Product Description
Table 83: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Companion Diagnostic Test - Plavix - Product Status
Table 85: Companion Diagnostic Test - Plavix - Product Description
Table 86: Astute Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Diagnostic Test - Acute Coronary Syndrome - Product Status
Table 88: Diagnostic Test - Acute Coronary Syndrome - Product Description
Table 89: Aterovax SA Pipeline Products & Ongoing Clinical Trials Overview
Table 90: AteroDx Combo - Product Status
Table 91: AteroDx Combo - Product Description
Table 92: AteroDx ISO - Product Status
Table 93: AteroDx ISO - Product Description
Table 94: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Status
Table 95: sPLA2 Atherosclerosis Test - Asymptomatic Patients - Product Description
Table 96: Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Cardiac Troponin Biomarker Kit - Product Status
Table 98: Cardiac Troponin Biomarker Kit - Product Description
Table 99: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Multiplexed Detection - BNP - Product Status
Table 101: Multiplexed Detection - BNP - Product Description
Table 102: Multiplexed Detection - CRP - Product Status
Table 103: Multiplexed Detection - CRP - Product Description
Table 104: Multiplexed Detection - Myoglobin - Product Status
Table 105: Multiplexed Detection - Myoglobin - Product Description
Table 106: Multiplexed Detection - Troponin - Product Status
Table 107: Multiplexed Detection - Troponin - Product Description
Table 108: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 109: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Status
Table 110: SYNCHRON LXi 725 Anti-Cardiolipin Assay - Product Description
Table 111: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Status
Table 112: SYNCHRON LXi 725 Ischemia Modified Albumin Assay - Product Description
Table 113: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Status
Table 114: UniCel DxC 600i Synchron Access ß2-Glycoprotein 1 Ab Assay - Product Description
Table 115: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 116: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status
Table 117: BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description
Table 118: BGM Galectin-3 Test - Onset Heart Failure - Product Status
Table 119: BGM Galectin-3 Test - Onset Heart Failure - Product Description
Table 120: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 121: Biomarker Assay - Acute Cardiac Stress - Product Status
Table 122: Biomarker Assay - Acute Cardiac Stress - Product Description
Table 123: Biomarker Assay - Congestive Heart Failure - Product Status
Table 124: Biomarker Assay - Congestive Heart Failure - Product Description
Table 125: Evalution - Cardiac Assay - Product Status
Table 126: Evalution - Cardiac Assay - Product Description
Table 127: Biomarker Design Forschungs GmbH Pipeline Products & Ongoing Clinical Trials Overview
1.2 List of Figures
Figure 1: Cardiac Markers Tests - Pipeline Products by Stage of Development
Figure 2: Cardiac Markers Tests - Pipeline Products by Segment
Figure 3: Cardiac Markers Tests - Pipeline Products by Territory
Figure 4: Cardiac Markers Tests - Pipeline Products by Regulatory Path
Figure 5: Cardiac Markers Tests - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Markers Tests - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report